TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 61,115 | 50,824 | 55,651 |
Financial expenses | 0 | 0 | 2 |
Earnings before taxes | 6,461 | 6,883 | 9,932 |
EBITDA | 6,485 | 7,117 | 10,186 |
Total assets | 15,733 | 18,980 | 22,608 |
Current assets | 14,015 | 18,304 | 22,034 |
Current liabilities | 10,530 | 14,367 | 17,864 |
Equity capital | 5,203 | 4,612 | 4,743 |
- share capital | 101 | 95 | 98 |
Employees (average) | 14 | 13 | 12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 33.1% | 24.3% | 21.0% |
Turnover per employee | 4,365 | 3,910 | 4,638 |
Profit as a percentage of turnover | 10.6% | 13.5% | 17.8% |
Return on assets (ROA) | 41.1% | 36.3% | 43.9% |
Current ratio | 133.1% | 127.4% | 123.3% |
Return on equity (ROE) | 124.2% | 149.2% | 209.4% |
Change turnover | 6,685 | -3,155 | 2,513 |
Change turnover % | 12% | -6% | 5% |
Chg. No. of employees | 1 | 1 | 2 |
Chg. No. of employees % | 8% | 8% | 20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.